Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Harmony Biosciences Holdings, Inc. (HRMY) and Illumina (ILMN). But which of these two ...

Illumina has been on fire lately. In the past six months alone, the company’s stock price has rocketed 47%, reaching $121.93 ...

We just received data on a new analyst forecast for $ILMN. Sung Ji Nam from Scotiabank set a price target of 125.0 for ILMN. To track analyst ratings and price ...

Illumina Inc. (NASDAQ:ILMN) is currently in Phase 17 of its 18-phase Adhishthana Cycle on the weekly chart. A detailed structural analysis using the Adhishthana Principles reveals deeper issues that ...

Illumina (NASDAQ:ILMN) shares fell on Friday after Scotiabank cut its rating to Sector Perform from Sector Outperform, citing concerns over the company’s 2026 outlook and becoming the second brokerage ...

Illumina (ILMN) shares have shown steady movement recently, catching the attention of investors looking at biotech trends. With its latest quarterly performance, investors are considering how ongoing ...

Illumina, Inc. (NASDAQ:ILMN) reported better-than-expected earnings for the second quarter on Thursday. The company posted quarterly earnings of $1.19 per share which beat the analyst consensus ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Illumina (ILMN – Research Report) and Guardant Health (GH – Research Report) w ...

Illumina (ILMN) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.14 per share a year ago. These figures are ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Alkermes (ALKS) and Illumina (ILMN) ...